The abstract is read at the publisher; the summary is JClub's.
TRAIT enables rapid modular assembly of CRISPR/Cas- and integrase-mediated mammalian genome integration donors by separating targeting elements from Gateway-compatible payloads.
- Why it matters: Building engineered mammalian cell models repeatedly requires labor-intensive redesign of integration donors, even when modular assembly exists. TRAIT addresses the bottleneck of adapting existing expression cassettes across genome-engineering applications.
- What they did: The framework combines direct Golden Gate assembly of targeting elements with Gateway-mediated payload transfer, using vector modules for multiple integration and control strategies. It supports workflows including MultiSite Gateway and functional validation in human cells, plus generation of human induced pluripotent stem cells with doxycycline-inducible Cas9.
- The result: In human cells, TRAIT validated targeted integration, recombinase-mediated cassette exchange, and multiplexed genome editing, and it produced iPSCs with functional doxycycline-inducible Cas9 and landing-pad constructs. This provides an interoperable toolbox for assembling and deploying diverse genome-engineering constructs in mammalian systems.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.